Cambridge Cognition collaborates in virtual study for COVID-19 healthcare workers

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, is collaborating with 4YouandMe and The Center for International Emergency Medical Services to investigate the utility of wearables and mobile phones to measure stress recovery in frontline healthcare workers in the USA caring for COVID-19 positive patients. This virtual study will take place over 6-12 months with up to 500 participants. The project is charity funded and Cambridge Cognition are supporting the project by providing the digital cognitive assessments.

Many healthcare workers worldwide are experiencing high levels of stress as they work on the frontline caring for COVID-19 positive patients. Stress negatively affects the immune system1, which in turn can increase susceptibility to infection. Accurate measurement of stress responses in real-time will be key to better understanding whether stress is a significant risk factor for frontline healthcare workers contracting COVID-19.  

Carrying a mobile phone or wearable is now a habit for most, so the devices are ideally suited to capture subtle fluctuations in wellbeing. The primary goal of the project is to determine whether mobile phones and wearables are a feasible means of detecting and tracking real-time changes in stress and recovery as frontline healthcare workers transition between “on-shift” and “off-shift” with COVID-19 patients. The secondary goal is to determine whether these digital signals can inform risk-detection for COVID-19 infectivity.

Cambridge Cognition is the cognitive assessment partner for this exploratory research project: supporting the identification of clinically meaningful signs of stress, such as mood shifts and changes in cognitive performance.

Matthew Stork, Chief Executive Officer of Cambridge Cognition, said:

“Tracking stress and recovery for frontline healthcare workers is important research and we are pleased to provide our cognitive assessment expertise for this project. Wearables and mobile phones are unparalleled for tracking real-time responses and Cambridge Cognition has extensive experience in virtual trials such as this. We hope that the environment for healthcare workers may be improved in the future as a result of the objective information gathered in the study.”

Stephen Friend, President and Co-Founder of 4YouandMe, said:

“Our study, that has been enrolling well in the US, is designed to explore how the stressful conditions among frontline healthcare workers might be collected objectively in terms of the immediate and intermediate effects of stress. For several years, we have probed the stress effects on mood, sleep, and cognition. We are thrilled that the well-designed world-class measures we would hope to engage have been provided by Cambridge Cognition. The power and ease of the Cambridge Cognition tools will go a long way to helping us better understand the links between stress and momentary shifts in cognition and in turn hopefully this will allow us to better protect all essential frontline health workers in the near future.”

Reference:  Pruett SB. Stress and the immune system. Pathophysiology. 2003 May 1;9(3):133-53.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Cambridge Cognition Holdings

More articles like this

Cambridge Cognition Holdings

Cambridge Cognition forms new Scientific Advisory Board

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, is pleased to announce the formation of a Scientific Advisory Board. This expert board will provide scientific guidance and valuable market insights, primarily focusing

Cambridge Cognition Holdings

Cambridge Cognition Holdings Changes its Auditor to Crowe UK LL

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Board has approved the appointment of Crowe UK LLP as the Group’s new external auditor following a competitive

Cambridge Cognition Holdings

Cambridge Cognition strengthens balance sheet with £3 million loan

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Company has obtained a £3.0 million loan from Claret European Specialty Lending Company III, S.à r.l.  Claret specialises in

Cambridge Cognition Holdings

Cambridge Cognition Holdings Revision to Explanatory Note

Cambridge Cognition (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the explanatory note to Resolution 7 in the Notice of the Annual General Meeting (“AGM”) to be held on 28 June 2023

Cambridge Cognition Holdings

Cambridge Cognition publishes Annual Report and Accounts

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has confirmed that the Annual Report and Accounts for the year ended 31 December 2022 and the Notice of the Annual General

Cambridge Cognition Holdings

Cambridge Cognition growth strategy clearly paying off (VIDEO)

Cambridge Cognition Holdings plc (LON:COG) CEO Matthew Stork joins DirectorsTalk Interviews to discuss prelim results for the year ended 31 December 2022. In this interview Matthew talks us through the result highlights, explains how the the acquisitions